Journal article · 2024 · Open access

A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy

Jing Gao, Xingyu Jiang, Shumin Lei, Wenhao Cheng, Yi Lai, Min Li, Lei Yang, Peifeng Liu, Xiaohua Chen, Min Huang, Haijun Yu, Hui‐Xiong Xu and 1 more

Nature Communications, 15(1), 6608 · Published 4 August 2024 · DOI 10.1038/s41467-024-50735-w

Open PDFView at the publisherCite this paper

In brief

“A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy” is a 2024 journal article by Jing Gao and 12 co-authors, published in Nature Communications. OpenAlex counts 132 citations as of 21 November 2026, which puts it in the top 5% of works published in 2024 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Nature Communications.

Citations
132
Most cited in
2026 (80)
Field-weighted impact
12.87
References
52
Authors
13

Abstract

The antitumor performance of PROteolysis-TArgeting Chimeras (PROTACs) is limited by its insufficient tumor specificity and poor pharmacokinetics. These disadvantages are further compounded by tumor heterogeneity, especially the presence of cancer stem-like cells, which drive tumor growth and relapse. Herein, we design a region-confined PROTAC nanoplatform that integrates both reactive oxygen species (ROS)-activatable and hypoxia-responsive PROTAC prodrugs for the precise manipulation of bromodomain and extraterminal protein 4 expression and tumor eradication. These PROTAC nanoparticles selectively accumulate within and penetrate deep into tumors via response to matrix metalloproteinase-2. Photoactivity is then reactivated in response to the acidic intracellular milieu and the PROTAC is discharged due to the ROS generated via photodynamic therapy specifically within the normoxic microenvironment. Moreover, the latent hypoxia-responsive PROTAC prodrug is restored in hypoxic cancer stem-like cells overexpressing nitroreductase. Here, we show the ability of region-confined PROTAC nanoplatform to effectively degrade BRD4 in both normoxic and hypoxic environments, markedly hindering tumor progression in breast and head-neck tumor models. Antitumor performance of PROteolysis-TArgeting Chimeras (PROTACs) is limited by their targeting ability and retention to tumor sites. Here the authors design the reactive oxygen species (ROS)-activatable and hypoxia-responsive PROTAC nanoparticles with selective penetration into tumors for degradation of BRD4 to suppress breast and head and neck cancer progression.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gao, J., Jiang, X., Lei, S., Cheng, W., Lai, Y., Li, M., Yang, L., Liu, P., Chen, X., Huang, M., Yu, H., Xu, H., & Xu, Z. (2024). A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy. Nature Communications, 15(1), 6608. https://doi.org/10.1038/s41467-024-50735-w

MLA 9

Gao, Jing, et al. “A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy.” Nature Communications, vol. 15, no. 1, 2024, p. 6608. https://doi.org/10.1038/s41467-024-50735-w.

Chicago

Gao, Jing, Xingyu Jiang, Shumin Lei, Wenhao Cheng, Yi Lai, Min Li, Lei Yang, et al. 2024. “A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy.” Nature Communications 15 (1): 6608. https://doi.org/10.1038/s41467-024-50735-w.

Harvard

Gao, J. et al. (2024) ‘A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy’, Nature Communications, 15(1), p. 6608. doi:10.1038/s41467-024-50735-w.

IEEE

J. Gao et al., “A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy,” Nature Communications, vol. 15, no. 1, p. 6608, 2024, doi: 10.1038/s41467-024-50735-w.

BibTeX

@article{gao2024region,
  title     = {{A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy}},
  author    = {Gao, Jing and Jiang, Xingyu and Lei, Shumin and Cheng, Wenhao and Lai, Yi and Li, Min and Yang, Lei and Liu, Peifeng and Chen, Xiaohua and Huang, Min and Yu, Haijun and Xu, Hui‐Xiong and Xu, Zhiai},
  journal   = {Nature Communications},
  year      = {2024},
  volume    = {15},
  number    = {1},
  pages     = {6608},
  doi       = {10.1038/s41467-024-50735-w},
  url       = {https://doi.org/10.1038/s41467-024-50735-w}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202422
20255050
20268080

Its field-weighted citation impact is 12.87: it has been cited 12.87 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • protein degradation
  • BRD4
  • cancer stem-like cells
  • tumor heterogeneity
  • nitroreductase
  • MMP-2
  • photodynamic therapy

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Gao, J., Jiang, X., Lei, S., Cheng, W., Lai, Y., Li, M., Yang, L., Liu, P., Chen, X., Huang, M., Yu, H., Xu, H., & Xu, Z. (2024). A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy. Nature Communications, 15(1), 6608. https://doi.org/10.1038/s41467-024-50735-w

How many times has this paper been cited?

132 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature Communications: sign in and open the PDF from this page.

Who wrote this paper?

Jing Gao, Xingyu Jiang, Shumin Lei, Wenhao Cheng, Yi Lai, Min Li, Lei Yang, Peifeng Liu, Xiaohua Chen, Min Huang, Haijun Yu, Hui‐Xiong Xu and 1 more.

What is the DOI of this paper?

10.1038/s41467-024-50735-w, permanently at https://doi.org/10.1038/s41467-024-50735-w. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.